HOO HOO HOOSIERS!!!!!
20.01.2026 04:45 — 👍 1 🔁 0 💬 0 📌 0@malutansey.bsky.social
Stanford, UTSW, WashU, Emory, UF & now Indiana Uni SOM Stark Neuroscience. Latina, mother, daughter. Immunity inflammation lysosomes neuroimmuno neurodegen, EIC NPJPARKD. Posts my own.
HOO HOO HOOSIERS!!!!!
20.01.2026 04:45 — 👍 1 🔁 0 💬 0 📌 0Thank you for amplifying Mackenzie Bolen’s work 🤓🤩😎💪🏼
20.01.2026 04:45 — 👍 0 🔁 0 💬 0 📌 0
Spatial single-cell multiomics from @malutansey.bsky.social & colleagues reveals peripheral immune dysfunction in #Parkinsons & inflammatory bowel disease; "Findings suggest iron mishandling along the gut barrier likely contributes to systemic inflammation"
www.nature.com/articles/s41...
Wrapping up #CTAD2025 in #SanDiego today and it’s back to winter in #Indy 😍😎🤩
04.12.2025 16:09 — 👍 2 🔁 0 💬 0 📌 0The weather and the science were both stellar at #CTAD2025 in #SanDiego
04.12.2025 16:07 — 👍 2 🔁 0 💬 0 📌 0Lots of #sciencerockstar sightings at #CTAD2025
04.12.2025 16:05 — 👍 3 🔁 0 💬 0 📌 0It’s been an incredibly exciting and productive week at #CTAD2025 in sunny #SanDiego
04.12.2025 16:03 — 👍 0 🔁 0 💬 0 📌 0
New paper (involving @malutansey.bsky.social et al) explores how LRRK2, GCase, & Cathepsin are affected in primary immune cells from #Parkinsons patients after stimulation with cytokine IFN-γ; LRRK2 levels, Rab10 phosphorylation, & cathepsin activity = largest effect
www.nature.com/articles/s41...
Thank you for highlighting our work in collaboration with @dzamkolab
01.12.2025 12:11 — 👍 0 🔁 0 💬 0 📌 0
New paper from @malutansey.bsky.social et al reports that #Parkinsons -linked LRRK2 & GBA1 variants converge on peripheral blood immune cell dysregulation; LRRK2 inhibitors & GCase activators modulate ex vivo response to bacterial exposure
movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
A fantastic day attending thr Midwest/Great Lakes Undergraduate Research Symposium at Oberlin College. So many talented researchers with a bright future ahead. @btlamb.bsky.social, @malutansey.bsky.social #goteamstark
01.11.2025 14:20 — 👍 4 🔁 2 💬 0 📌 0
Excited and proud to share this publication from Julian Mark #TanseyLab3ptO MDPhD at Univ of Florida and team including his lab mentor Rebecca Wallings in collaboration Dzamko lab at Univ of Sydney and Garrido lab in Barcelona funded by MJFF
doi.org/10.1002/mds....
Great tag team #SNRI SEMINAR @iusm by Phil Popovich and Dana McTigue from The Ohio State
03.10.2025 02:17 — 👍 7 🔁 1 💬 0 📌 0
Bial provide an update on their Phase 2 "ACTIVATE" study (NCT05819359), evaluating the efficacy, safety, tolerability, PK/PD of their GCase activator BIA 28-6156 in 273 genetically confirmed GBA1-associated #Parkinsons patients; LPLV=April 2026
www.bial.com/en/media/new...
WPC Vice-President, Professor @malutansey.bsky.social shares about the Fuel the Future of #Parkinsons Science campaign to support early-career researchers by providing travel grants to attend the 7th World Parkinson Congress #wpc2026 in May 2026 in #Phoenix.
Support -> wpc2026.org/supportresea...
Thank you Stephen Curry for your leadership on this exciting blog post and collaborative publication in @PLOSBIOLOGY on ending #publicationbias written after a workshop hosted by The National Institutes of Health. occamstypewriter.org/scurry/2025/...
25.09.2025 12:52 — 👍 1 🔁 0 💬 0 📌 0Incredibly impressed during the VIB-Ghent Center for Inflammation Research site visit. Congrats to its Director Bart Lambrecht and the entire team 🤓🧠💪🏼
18.09.2025 14:58 — 👍 3 🔁 0 💬 0 📌 0
New review from @malutansey.bsky.social & colleagues explores iron mishandling in the brain & periphery in #Parkinsons, & proposes that iron dysregulation outside the brain is an important catalyst that may represent a prodromal mechanistic link in gut-first PD
www.nature.com/articles/s41...
Great visit to the IU Gill Institute for Neuroscience in Bloomington 🤓🤩 hosted by Hui-Chen Lu
30.08.2025 11:38 — 👍 4 🔁 0 💬 0 📌 1It’s important to focus on our own sphere of influence in these challenging times so thank you #ALZIN Indiana chapter of @alzassociation.bsky.social for hosting Cocktails & Conversation at #LiterHouse
29.08.2025 03:29 — 👍 3 🔁 0 💬 0 📌 0Thank you Josh Kulas for the excellent tour of the #IndianaBiosciencesResearchInstitute #IBRI. Looking forward to collaborating with you on #neuroimmunology studies in the #neuroinflammation & #neurodegeneration space 🤓💪🏼🧠🤩 l
27.08.2025 11:53 — 👍 4 🔁 1 💬 0 📌 0Excited to share this review from Mackenzie Bolen Kelly Menees, PhD and University of Florida UG Aidan Dupreez in #TanseyLab3ptO on #irondysregulation in the #brain and #periphery in #Parkinsons. www.nature.com/articles/s41...
19.08.2025 03:03 — 👍 5 🔁 2 💬 0 📌 0
If you missed it here’s the video link
www.youtube.com/watch?v=CQM6...
Women with Down syndrome may develop Alzheimer's disease more rapidly than men news.uci.edu/2025/08/12/w... by @ucirvine.bsky.social
#Alzheimers #dementia #DownSyndrome #WomensHealth @elizabethhead.bsky.social
Thank you for amplifying this @leadcoalition.bsky.social 🤓
12.08.2025 02:10 — 👍 1 🔁 0 💬 0 📌 0Sharing an Op Ed that came out this morning in @rcscience.bsky.social
12.08.2025 02:09 — 👍 9 🔁 1 💬 0 📌 0
Please join me for this #Debate on Monday Aug 11 at noon Eastern w my colleague Alberto Espay on the role of #proteinopathies in #neurodegenerativediseases Indiana University School of Medicine #NeurologyGrandRounds Zoom link in QR code
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
Please join me for this #Debate on Monday Aug 11 at noon Eastern w my colleague Alberto Espay on the role of #proteinopathies in #neurodegenerativediseases Indiana University School of Medicine #NeurologyGrandRounds Zoom link in QR code
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
It’s a wrap in #Toronto for @alzassociation.bsky.social #AAIC25 🤓. See you in #London for #AAIC26 😎💜🧠
03.08.2025 03:03 — 👍 13 🔁 1 💬 1 📌 0Exciting topline results from a #Phase2 trial in #Alz presented at #AAIC25 by #INmuneBio showing #solTNFinhibition by #XPro1595 in amyloid positive patients with 2+ biomarkers of inflammation in blood slowed cognitive decline in a 6 mo trial 🤓💪🏼💜🧠
03.08.2025 03:01 — 👍 2 🔁 0 💬 0 📌 0